NanoDrug Delivery

Nanodrug Delivery is developing nanoparticle-based technology that specifically improves the transport and distribution of active ingredients in the body. The aim is to increase the effectiveness of drugs—for example, in chemotherapy—while reducing side effects.
In doing so, the start-up supports pharmaceutical companies in optimizing promising active ingredients that might otherwise not receive approval, thereby creating long-term access to more effective and better tolerated therapies for patients.

04/2023 First Pitch at Life Science Start-Up Day 2023 in Göttingen
2024 Company founded
05/2024 Winner of the Audience Award of the Lift-Off Competition
05/2024 Winner of the the Special Prize in Life Sciences of the Lift-Off Competition
09/2024 Winner of the WEGBEREITER Startup-Preis 2024
11/2024 Winner of the Innovation Award of Lower Saxony 2024
10/2025 Accepted for the HTI BioIntelligence Programme
David Rudolph, CEO
Prof. Frauke Alves
Quotemark Icon

"The HTI programmes have had a significant impact on our start-up’s growth, with the coaching/mentoring and financial support that has been provided. Through the programme, we have achieved milestones and gained a clearer understanding of our strategy and needs. Beyond the financial aspects, what stands the HTI out is the intense support & dedicated guidance and resources provided."

David Rudolph